These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 609627)

  • 1. [Evaluation of the effectiveness of different combinations of antituberculosis drugs in the treatment of pulmonary TB (author's transl].
    Zorić M; Jarebica M; Teofanović D; Toula Z; Milicević N
    Plucne Bolesti Tuberk; 1977; 29(3-4):207-17. PubMed ID: 609627
    [No Abstract]   [Full Text] [Related]  

  • 2. [Evaluation of an antituberculosis program in Ivory Coast. A study of the prospects of a short treatment (author's transl)].
    Auzanneau G; Vindrios J; Bretton G; Bretton R; Gateff C
    Med Trop (Mars); 1979; 39(2):221-9. PubMed ID: 226829
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment effectiveness in newly detected destructive pulmonary tuberculosis using different combinations of chemical preparations].
    Pospelov VV; Pashkov IuN
    Probl Tuberk; 1982 Mar; (3):38-40. PubMed ID: 7088921
    [No Abstract]   [Full Text] [Related]  

  • 4. A clinical study on controlled therapy in newly-diagnosed pulmonary tuberculosis using combinations of antituberculosis drugs by the daily continuous and intermittent methods.
    Arch Immunol Ther Exp (Warsz); 1976; 24(2):169-84. PubMed ID: 1275660
    [No Abstract]   [Full Text] [Related]  

  • 5. [Side effects of antituberculous drugs observed within six months after admission. Tuberculosis Research Committee, Ryoken (author's transl)].
    Kekkaku; 1975 Jun; 50(6):161-7. PubMed ID: 1185917
    [No Abstract]   [Full Text] [Related]  

  • 6. [Direct and late results of the treatment of severe cases of primary tuberculosis by Pronisone and antituberculous drugs (author's transl)].
    Djurić-Milosavljević O; Moskovljević D
    Plucne Bolesti Tuberk; 1979; 31(3-4):125-9. PubMed ID: 538114
    [No Abstract]   [Full Text] [Related]  

  • 7. [Short-course chemotherapy for pulmonary tuberculosis (author's transl)].
    Yamamoto K
    Kekkaku; 1978 Aug; 53(8):401-6. PubMed ID: 703041
    [No Abstract]   [Full Text] [Related]  

  • 8. [Side-effects of antituberculous drugs observed in five different regimens (author's transl)].
    Aizawa H; Sakai K; Kishida K
    Kekkaku; 1977 May; 52(5):229-34. PubMed ID: 886680
    [No Abstract]   [Full Text] [Related]  

  • 9. [Controlled trial of isoniazid.rifampicin.ethambutol regimen and isoniazid.rifampicin.pyrazinamide regimen in the primary chemotherapy for pulmonary tuberculosis (author's transl)].
    Kekkaku; 1980 Jan; 55(1):7-13. PubMed ID: 6988627
    [No Abstract]   [Full Text] [Related]  

  • 10. [Study on the efficacy and safety of short-term treatment including fluoroquinolones anti-tuberculosis drugs for rifampicin resistant pulmonary tuberculosis].
    Kang WL; Xie YG; Tan WG; Chu NH; Li L; You YH; Yang YZ; Wang XM; Yan XL; Miao ZP; Duanmu HJ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Feb; 30(2):179-83. PubMed ID: 19565883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A case of tuberculosis with a transient aggravation during initial phase of chemotherapy (author's transl)].
    Kishimoto H; Kawachi H; Shimokata K
    Kekkaku; 1982 Feb; 57(2):95-8. PubMed ID: 7069978
    [No Abstract]   [Full Text] [Related]  

  • 12. [Symposium: problem of retreated pulmonary tuberculosis (author's transl)].
    Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1979; 2(4):237-40. PubMed ID: 555435
    [No Abstract]   [Full Text] [Related]  

  • 13. [Drug combinations and duration of the regimen at the initial treatment of tuberculosis].
    Hara K
    Kekkaku; 1983 Sep; 58(9):492-5. PubMed ID: 6663964
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical and laboratory studies in patients with pulmonary tuberculosis treated with pyrazinamide].
    Savula MM; Smolenko MI; Romaniuk MD; Slivka IuI
    Probl Tuberk; 1990; (11):25-8. PubMed ID: 2290809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Analysis of causes of drug resistance and therapeutic effects on 27 multi-drug resistant pulmonary tuberculosis patients].
    Ye Z; Pei X; Yang Y
    Zhonghua Jie He He Hu Xi Za Zhi; 1997 Aug; 20(4):234-6. PubMed ID: 10072811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A survey on the duration of chemotherapy for pulmonary tuberculosis patients in Japan (author's transl)].
    Kekkaku; 1978 Sep; 53(9):471-6. PubMed ID: 713226
    [No Abstract]   [Full Text] [Related]  

  • 17. [Experimental model of the short-course chemotherapy (author's transl)].
    Toyohara M
    Kekkaku; 1979 Jul; 54(7):369-74. PubMed ID: 513435
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effectiveness of tuberculin and chemotherapy in destructive forms of pulmonary tuberculosis].
    Stamboltsian EP; Saakian AL; Oganesian LO; Megrabian SA; Apresian EA
    Probl Tuberk; 1981 Apr; (4):69-70. PubMed ID: 7255378
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effectiveness of abbreviated biphasic treatment in pulmonary tuberculosis].
    Cramer G
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1981; 30(3):177-80. PubMed ID: 6273990
    [No Abstract]   [Full Text] [Related]  

  • 20. [Early and late results of 6-month treatment of pulmonary tuberculosis with various drug combinations].
    Rogowski J; Zierski M; Bek E; Snider DE; Long MW
    Pneumonol Pol; 1982 Sep; 50(9):425-35. PubMed ID: 7163000
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.